Li, T., Providencia, R., Mu, N., Yin, Y., Chen, M., Wang, Y., . . . Ma, H. (2021). Association of metformin monotherapy or combined therapy with cardiovascular risks in patients with type 2 diabetes mellitus. Cardiovasc Diabetol.
Style de citation ChicagoLi, Tian, et al. "Association of Metformin Monotherapy or Combined Therapy With Cardiovascular Risks in Patients With Type 2 Diabetes Mellitus." Cardiovasc Diabetol 2021.
Style de citation MLALi, Tian, et al. "Association of Metformin Monotherapy or Combined Therapy With Cardiovascular Risks in Patients With Type 2 Diabetes Mellitus." Cardiovasc Diabetol 2021.
Attention : ces citations peuvent ne pas être correctes à 100%.